Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2008

01-04-2008 | Original Article

Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer

Authors: Yutaka Yonemura, Cheng-Chung Wu, Norimasa Fukushima, Ichirou Honda, Etsurou Bandou, Taiichi Kawamura, Tohru Kamata, Byung-Sik Kim, Nobuo Matsuki, Toshiharu Sawa, Sung-Hoon Noh, the East Asia Surgical Oncology Group

Published in: International Journal of Clinical Oncology | Issue 2/2008

Login to get access
Metadata
Title
Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer
Authors
Yutaka Yonemura
Cheng-Chung Wu
Norimasa Fukushima
Ichirou Honda
Etsurou Bandou
Taiichi Kawamura
Tohru Kamata
Byung-Sik Kim
Nobuo Matsuki
Toshiharu Sawa
Sung-Hoon Noh
the East Asia Surgical Oncology Group
Publication date
01-04-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0727-1

Other articles of this Issue 2/2008

International Journal of Clinical Oncology 2/2008 Go to the issue

Original Article

Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer

Introduction to Review Articles

Cancer registration system: an introduction

Case Report

Small cell carcinoma of the prostate treated with amrubicin

Original Article

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum

From the Asco-Jsco Joint Symposium

Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan

Case Report

Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits